These findings may lead to new therapeutic applications for DHA and NPD1 for treating and preventing many brain and retinal conditions and diseases, such as age-related macular degeneration and Alzheimer and Parkinson diseases.AcknowledgmentsWe thank Dr. Huda Zoghbi for the ataxin-1 and huntingtin expression constructs used in this report and for invaluable input; Stephen Prescott and Dan A. Dixon